WEDNESDAY, OCTOBER 28 | 7:00 PM EASTERN
Speakers:
- Anna Poleggi, PhD, Istituto Superiore di Sanità, Rome
Investigating the influence of CYP4X1 gene of age at onset of CJD as potential preventive therapeutic approach
- Qingzhong Kong, PhD, Case Western Reserve University
The RAP approach for effective prevention and treatment of prion diseases
- Natalia do Carmo Ferreira de Araujo, PhD, Rocky Mountain Laboratories, NIH/NIAID
Evaluation of new anti-prion drugs: from drug design to therapeutic efficacy against human prions in vitro, ex-vivo and in vivo
Moderator:
- Richard Knight, BA, BM BCh, FRCP(E), Chair, Management Committee, the UK CJD Support Network